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Summary
Streptomyces albus J1074 is a streptomycete strain
widely used as a host for expression of secondary
metabolite gene clusters. Bioinformatic analysis of
the genome of this organism predicts the presence of
27 gene clusters for secondary metabolites. We have
used three different strategies for the activation of
some of these silent/cryptic gene clusters in S. albus
J1074: two hybrid polyketide-non-ribosomal peptides
(PK-NRP) (antimycin and 6-epi-alteramides), a type I
PK (candicidin), a non-ribosomal peptides (NRP)
(indigoidine) and glycosylated compounds (paulomy-
cins). By insertion of a strong and constitutive pro-
moter in front of selected genes of two clusters,
production of the blue pigment indigoidine and of
two novel members of the polycyclic tetramate
macrolactam family (6-epi-alteramides A and B) was
activated. Overexpression of positive regulatory
genes from the same organism also activated the
biosynthesis of 6-epi-alteramides and heterologous
expression of the regulatory gene pimM of the
pimaricin cluster activated the simultaneous produc-
tion of candicidins and antimycins, suggesting some
kind of cross-regulation between both clusters. A
cluster for glycosylated compounds (paulomycins)
was also identified by comparison of the high-
performance liquid chromatography profiles of the
wild-type strain with that of a mutant in which two
key enzymes of the cluster were simultaneously
deleted.
Introduction
Actinomycetes are Gram-positive bacteria belonging to
the phylum Actinobacteria, one of the largest taxonomic
groups within the domain Bacteria (Gao and Gupta,
2012). Filamentous actinomycetes are characterized by a
complex life cycle of morphological differentiation that
starts with the germination of a spore to give a substrate
mycelium and later an aerial mycelium, followed then by
a sporulation stage (Chater, 1998). Actinobacteria are
widely distributed in terrestrial, especially soil, and aquatic
ecosystems (McCarthy and Williams, 1992; Stach and
Bull, 2005). They are important for soil formation by
decomposing and recycling complex mixtures of poly-
mers in dead plant, animal and fungal materials using
extracellular enzymes (McCarthy and Williams, 1992).
They also exhibit diverse physiological and metabolic
properties, such as the production of volatile substances
(Gust et al., 2003) and a wide variety of secondary
metabolites, many of which are potent antibiotic, antifun-
gal, antitumor, immunosuppressant, antiviral or antipara-
sitic agents. Among these compounds, some structural
types such as polyene macrolides, large-membered
macrolides, anthracyclines, polyethers, cyclopolylac-
tones, aminoglycosides, streptothricins, actinomycins
and quinoxaline peptides are produced almost exclu-
sively by actinomycetes. In addition, glycopeptides and
orthosomycins are mainly produced by non-Streptomyces
species (Bérdy, 2012). This has turned actinomycetes into
the primary bioactive metabolite-producing organisms
exploited by the pharmaceutical industry and has
prompted the study of these microorganisms at all levels:
taxonomy, genetics and physiology (Hopwood, 1999).
Since the development of recombinant DNA technol-
ogy, an increasing number of biosynthesis gene clusters
for bioactive metabolites have been isolated and charac-
terized from actinomycetes, leading to the development of
genetic engineering approaches to develop new bioactive
compounds (Olano et al., 2011). In the last decade, the
increasing efficiency and reduced cost of DNA sequenc-
ing has prompted researchers to join whole prokaryotic
genome-sequencing projects (Lasken, 2012; Loman
et al., 2012). At the present time, at least 5611 bacterial
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genomes are available, 779 corresponding to actinobac-
terias and among them 214 to Streptomyces species
(http://www.ncbi.nlm.nih.gov/genomes/MICROBES/microbial
_taxtree.html). This, together with the improvement of
bioinformatics annotation (Torrieri et al., 2012; Wood
et al., 2012) and biosynthesis gene clusters search tools
(Fedorova et al., 2012) has shown that the metabolic
capabilities of microorganisms known to produce
bioactive compounds have been clearly underestimated
(Nett et al., 2009). Some of the first sequenced
actinomycete genomes corresponded to Streptomyces
avermitilis, Streptomyces coelicolor, Saccharopolyspora
erythraea, Salinispora tropica or S. griseus, producers of
avermectin, actinorhodin, erythromycin, salinosporamide
and streptomycin respectively (Nett et al., 2009). Analysis
of these genome sequences has revealed the presence of
numerous biosynthetic gene clusters (18 to 37) that might
be involved in the biosynthesis of additional secondary
metabolites belonging to different structural classes (Nett
et al., 2009). These gene clusters are defined as cryptic or
orphan because the identity of the natural product of the
encoded pathway is unknown. The putative structure of
these metabolites can be predicted, in some cases, using
bioinformatics tools that take into consideration the func-
tion of the genes present in the cluster (Ziemert and
Jensen, 2012). Various approaches have been described
through genome mining to confirm the function of these
pathways and to identify the products, including the acti-
vation of low- or non-expressed pathways, known as
silent pathways (Zerikly and Challis, 2009; Winter et al.,
2011).
Streptomyces albus J1074 is a derivative of S. albus G,
defective in both restriction and modification enzymes of
the SalI system (Chater and Wilde, 1976). Under normal
growth conditions, this strain is not known to produce any
bioactive natural product and it is widely used as a host for
expression of Streptomyces secondary metabolite gene
clusters (Baltz, 2010). In this work, we describe the iden-
tification of several compounds produced by S. albus
J1074 using genome-mining approaches and activation of
the expression of the corresponding gene clusters.
Results
Bioinformatic analysis of S. albus J1074 genome and
identification of secondary metabolite gene clusters
The S. albus J1074 genome was sequenced and anno-
tated by the Broad Institute (Cambridge, MA, USA),
the sequence being available since 2008. It contains
6 823 670 bp [73.2% guanine-cytosine (GC) content] of
which supercont3.1 genomic scaffold shotgun sequence
represents 6 813 830 bp (accession number NZ_
DS999645.1). This sequence comprises 5968 genes
coding for 5902 predicted proteins. At the time the
genome sequence was released, no production of sec-
ondary metabolites had been reported in S. albus J1074.
However, S. albus G, parental strain of S. albus J1074
(Chater and Wilde, 1976), was shown (after treatment
with N-methyl-N′-nitro-N-nitrosoguanidine and isolation of
mutant J1670) to produce paulomycins A and B (Majer
and Chater, 1987) and other S. albus strains were shown
to produce the polyether salinomycin (Izumikawa et al.,
2003a; Knirschová et al., 2007; Jiang et al., 2012;
Yurkovich et al., 2012). We searched the genome
sequence of S. albus J1074 chromosome using the
bioinformatic tool antibiotics and Secondary Metabolite
Analysis Shell (ANTISMASH) (Medema et al., 2011; Blin
et al., 2013), and we found 26 secondary metabolite
biosynthesis gene clusters predicted (Table 1). One addi-
tional cluster (cluster 23, Table 1), containing genes
directing the biosynthesis and attachment of deoxy-
hexoses, was not identified by ANTISMASH but rather by
specific search in the S. albus J1074 chromosome for
genes encoding Nucleotide DiPhosphate-stereochemistry
of sugar (NDP-D)-glucose synthase and NDP-D-glucose
4,6-dehydratase, both required for the biosynthesis of
6-deoxyhexoses.
Twelve clusters containing modular enzyme-coding
genes [polyketide synthase (PKS) or non-ribosomal
peptide synthetase (NRPS)] have been identified in
S. albus J1074. Two of them (clusters 5 and 6) contain
PKS genes belonging to type I and type III PKS respec-
tively. The first one (cluster 5) could correspond to a type
I PKS involved in the biosynthesis of a heptaene
macrolide of the polyene family because of its high degree
of similarity with the FR-008/candicidin cluster identified in
several streptomycetes such as S. griseus IMRU 3570,
Streptomyces sp. FR-008 or Streptomyces sp. S4
(Campelo and Gil, 2002; Chen et al., 2003; Seipke et al.,
2011). The other PKS cluster (cluster 6) contains a type III
PKS possibly involved in the production of 1,3,6,8-
tetrahydroxynaphthalene and its auto-oxidation product
flaviolin (Izumikawa et al., 2003b) because this cluster is
well conserved in several actinomycetes, particularly
S. coelicolor A3(2) and S. avermitilis MA-4680 (Nett et al.,
2009; Craney et al., 2013; Ikeda et al., 2013). In addition,
four clusters (clusters 1, 3, 4 and 26) contain hybrid type
I PKS-NRPS genes. In the case of clusters 1 and 3,
despite the fact that most of the amino acids incorporated
by each adenylation domain can be predicted by several
bioinformatic tools (Weber et al., 2009), it is quite hazard-
ous to propose even a presumptive structure for the
product of these clusters. On the other hand, cluster 4 and
26 might be involved in the biosynthesis of antifungal
compounds. Cluster 4 is conserved among different
Streptomyces in particular in Streptomyces sp. S4
(Seipke et al., 2011) and cluster 26 shows high similarity
to Lysobacter enzymogenes strain C3 cluster involved in
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the production of a heat-stable antifungal factor (Yu et al.,
2007). Six additional clusters are comprised of NRPS
genes, five of them not conserved in other actinomycetes
(clusters 12, 13, 14, 21 and 27). The NRPSs of two of
them show high similarity to lipopeptide biosynthesis gene
clusters (clusters 13 and 21), but for the same reasons
mentioned above, no presumptive structure can be pro-
posed. In addition, the NRPS-encoding gene sshg_00313
from cluster 9 shows a high degree of similarity to genes
involved in the biosynthesis of a blue pigment produced
by different bacteria such as Erwinia chrysanthemi or
several Streptomyces species (Reverchon et al., 2002;
Takahashi et al., 2007; Novakova et al., 2010; Yu et al.,
2013).
There are ten additional clusters involved in the
biosynthesis of other peptides or amino acidic compounds
such as siderophores (clusters 11 and 20), ribosomally
derived lantipeptides (clusters 2, 15 and 17), bacteriocins
(clusters 8, 16, 22 and 24) belonging to different families
and ectoine (cluster 10, Table 1). Cluster 11 might be
involved in the biosynthesis of desferrioxamine, a
cluster well conserved among different streptomycetes
(Barona-Gómez et al., 2004; 2006; Nett et al., 2009).
Cluster 10, present in most actinomycetes (Nett et al.,
2009), might determine the biosynthesis of osmopro-
tectant ectoine. The production of ectoine and
5-hydroxyectoine have been shown in S. coelicolor A3(2)
to be triggered upon exposure to high salinity or elevated
temperature (Bursy et al., 2008). Four clusters identified
by antiSMASH determine the production of known
terpenes (clusters 7, 18, 19 and 25) all of them also
produced by both S. coelicolor A3(2) and S. avermitilis
MA-4680 (Craney et al., 2013; Ikeda et al., 2013). Cluster
23 is the only one from S. albus J1074 identified by
the presence of genes determining the biosynthesis of
2,6-deoxyhexoses. This cluster contains in addition two
genes encoding glycosyltransferases (sshg_05324 and
sshg_05335).
Activation of a small NRPS cluster for the biosynthesis
of the blue pigment indigoidine
In order to activate some cryptic/silent gene clusters in
S. albus J1074, we decided to use a strategy based on
the insertion of a strong and constitutive promoter in front
of a selected gene of the cluster. We used the promoter
of the erythromycin resistance gene (ermE*p) of Sac.
erythraea (erythromycin producer). As a proof of concept,
we decided to apply this strategy to a small NRPS cluster.
In cluster 9, the sshg_00313 gene codes for a single
module NRPS that resembles the bpsA genes from
S. lavendulae (Takahashi et al., 2007) and from
Table 1. Secondary metabolite biosynthesis gene clusters identified in S. albus J1074 by genome mining.
Cluster Locationa Type Predicted producta
1 SSHG_00001–00036 Type I PKS-NRPS Unknown
2 SSHG_00040–00050 Lantipeptide Class II lantibiotic
3 SSHG_00051–00053 Type I PKS-NRPS Unknown
4 SSHG_00054–00069 Type I PKS-NRPS Antimycins
5 SSHG_00076–00101 Type I PKS Heptaene macrolide
6 SSHG_00144–00145 Type III PKS THN, flaviolin
7 SSHG_00244–00268 Terpene Isorenieratene
8 SSHG_00271 Bacteriocin Linocin M18-family
9 SSHG_00311–00315 NRPS Blue pigment
10 SSHG_00980–00990 Ectoine synthase 5-Hydroxyectoine
11 SSHG_01746–01756 Siderophore Desferrioxamine
12 SSHG_01964–02004 NRPS Unknown
13 SSHG_02468–02510 NRPS Lipopeptide
14 SSHG_02783–02815 NRPS Unknown
15 SSHG_03580–03598 Lantipeptide Class III lantibiotic
16 SSHG_03731 Bacteriocin Lactococcin 972-family
17 SSHG_03888–03912 Lantipeptide Class I lantibiotic
18 SSHG_04343–04344 Terpene Albaflavenone
19 SSHG_04630 Terpene Geosmin
20 SSHG_04857–04868 Siderophore Unknown
21 SSHG_04926–04963 NRPS Lipopeptide
22 SSHG_05166–05175 Bacteriocin Unknown
23b SSHG_05313–5354 Deoxysugars Glycosylated compound
24 SSHG_05575 Bacteriocin Unknown
25 SSHG_05647–05659 Terpene Hopene
26 SSHG_05699–05729 Type I PKS-NRPS Polycyclic tetramate macrolactam
27 SSHG_05882–05890 NRPS Unknown
a. Location and predicted products based on ANTISMASH analysis of S. albus J1074 genome sequence (accession number NZ_DS999645.1) and
individual BLAST analysis of selected genes.
b. Cluster 23 was not located by ANTISMASH analysis but only by Blast analysis of individual genes.
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S. aureofaciens (Novakova et al., 2010) and the indC
genes from S. chromofuscus (Yu et al., 2013) and from
Erwinia chrysanthemi (Reverchon et al., 2002). Analysis
of the amino acid sequence of this gene indicates that
would code for a NRPS containing an oxidation domain
that is embedded in an adenylation domain with the
signature sequence DAWQFGLINK for recognition
of L-glutamine. In addition, SSHG_00313 contains a
thiolation and thioesterase domains, structural organiza-
tion shared with the BpsA and IndC homologues previ-
ously mentioned. Surrounding the sshg_00313, there are
other genes for which homologues are also found in the
vicinity of bpsA and indC in Erwinia and Streptomyces
species such as: SSHG_00311 IndA-like, SSHG_00314
IndB-like, transmembrane transporter SSHG_00315
and phosphoribosyl transferase SSHG_00316. On the
other hand, SSHG_00312 encodes a 4-oxalocrotonate
tautomerase that is fused to S. chromofuscus IndC
NRPS. The indC-like bpsA gene is involved in the
biosynthesis of the blue pigment indigoidine by conden-
sation of two L-glutamines, this being the only activity
required to generate the blue pigment (Müller et al.,
2012). Under normal laboratory cultivation conditions, cul-
tures of S. albus J1074 on agar plates do not show any
blue pigmentation at all (Fig. 1A). Therefore, we consid-
ered that cluster 9 of S. albus J1074 might also be
involved in the biosynthesis of this pigment, its expression
being silent under normal cultivation conditions. To acti-
vate this small cluster, we inserted the ermE*p in front of
the sshg_00313 gene through homologous recombination
using plasmid pOJ313 (Fig. 1A), and the result was that
the resulting recombinant strain produced a blue colour
(Fig. 1B), indicating that expression of the cluster was
activated.
Activation and identification of a cluster for the hybrid
PK-NRP 6-epi-alteramides A and B
One of the clusters in S. albus (cluster 26) contains a
gene coding for a hybrid type I PKS-NRPS (sshg_05713).
This protein contains nine domains organized in two
modules, one PKS module containing ketosynthase,
acyltransferase, dehydratase, ketoreductase and acyl
carrier domains, and an NRPS module composed by
condensation, adenylation, peptidyl carrier protein and
thioesterase domains. The PKS acyltransferase might
incorporate malonate because it contains the character-
istic GHSxGE signature while the NRPS adenylation
domain would incorporate ornithine based in its con-
served motif and characteristic-binding pocket signature
DVGEIGSIDK. Surrounding the hybrid PKS-NRPS gene,
there are several other genes coding for enzymatic
activities possibly participating in the biosynthesis of a
hybrid polyketide-peptide compound (cyclase/dehydrase
SSHG_05711; flavin adenine dinucleotide-dependent
oxidoreductases SSHG_05714 and SSHG_05715; oxido-
reductase SSHG_05716; cytochrome P450 SSHG_
05717 and hydroxylase SSHG_05712). This cluster
showed similarity with other clusters from Streptomyces
sp. SPB74 and Streptomyces sp. SPB78 that have been
shown to be involved in the biosynthesis of the polycyclic
tetramate macrolactams frontalamides A and B (Blodgett
Fig. 1. A. Genetic organization of cluster 9 and S. albus J1074 phenotype when grown in R5A solid medium. The grey arrow shows the loca-
tion where the ermE*p was introduced using pOJ313. B. Genetic organization of activated cluster 9 and S. albus::pOJ313 phenotype when
grown in R5A solid medium.
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et al., 2010). To identify the compound synthesized by this
cluster in S. albus, we inserted independently the ermE*p
in front of sshg_05712 and of sshg_05713 using pOJ5712
and pOJ5713 respectively (Fig. 2A). Analysis by high-
performance liquid chromatography-mass spectrometry
(HPLC-MS) of ethyl acetate extracts of the corresponding
recombinant strains showed the appearance in the case
of the sshg_05712 gene of a peak with a mass of m/z 511
[M + H]+, and in the case of the sshg_05713 gene, the
same peak was observed and an additional peak with a
mass of m/z 495 [M + H]+ was also present (Fig. 2B).
Mass analysis allowed us to discard the possibility that
they were coincident with frontalamides A and B because
these compounds have a different mass [m/z 525 (M + H)+
and m/z 509 (M + H)+, respectively] and slightly different
absorption spectrum, and also to exclude other members
of the family such as ikarugamycin [mass m/z 481
(M + H)+], cylindramide [mass m/z 467 (M + H)+] or
dihydromaltophilin [mass m/z 513 (M + H)+]. The first peak
was detected as a very tiny peak in extracts of the wild-
type strain and the second one was undetected. The two
compounds were isolated, purified and their structures
elucidated by nuclear magnetic resonance (NMR) and
mass spectrometry (MS; see Supporting information) and
found to correspond to novel compounds 6-epi-alteramide
A and 6-epi-alteramide B (Fig. 2C). They differ in the
Fig. 2. A. Genetic organization of S. albus J1074 cluster 26. The grey arrows show the location where the ermE*p was introduced using
pOJ5712 and pOJ5713. B. UPLC chromatograms, monitored at 272 nm, of S. albus J1074, S. albus::pOJ5712, S. albus::pOJ5713 and
S. albus pEM4T5706 grown during 7 days in R5A liquid medium. C. Chemical structure of novel compounds 6-epi-alteramide A (1) and 6-epi-
alteramide B (2).
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presence of a hydroxyl group at C26 of 6-epi-alteramide
A, which is absent in 6-epi-alteramide B.
In the vicinity of sshg_05712, 7.6 kb upstream, we
found sshg_05706 that would code for a transcriptional
regulator of the LuxR-family. The region comprising from
sshg_05706 to sshg_05711 is not conserved in other clus-
ters involved in the biosynthesis of polycyclic tetramate
macrolactams (Blodgett et al., 2010). However, to assess
the possible involvement of SSHG_05706 in the regula-
tion of the biosynthesis of 6-epi-alteramides, we
expressed sshg_05706 under the control of ermE*p using
a high copy number plasmid (pEM4T5706). Streptomyces
albus J1704 expressing sshg_05706 overproduced 6-epi-
alteramide A and small amounts of 6-epi-alteramide B
were also detected (Fig. 2B).
Simultaneous activation of candicidins and antimycins
gene clusters
One of the largest clusters in S. albus J1074 genome is
that of a type I polyketide (sshg_00076 to sshg_00101)
that could code for a heptaene macrolide. It comprises a
region of approximately 137 kb, and it contains a large
number of type I PKS-coding genes. Most of the genes of
this cluster shows high similarity with genes involved in
the biosynthesis of the macrolide polyene FR-008/
candicidin (Campelo and Gil, 2002; Chen et al., 2003;
Seipke et al., 2011). Polyenes possess a characteristic
absorption spectrum with maxima at 230, 360, 380 and
400 nm. However, under different incubation conditions,
no clear peaks were detected in extracts of S. albus that
could indicate the presence of a polyene. To attempt the
activation of this cluster and to identify the compound it
codes, we used a regulatory gene from another cluster in
another organism. This was the pimM gene from the
pimaricin cluster in S. natalensis that codes for a positive
activator of the LuxR-family in the biosynthesis of
pimaricin (Antón et al., 2007). This gene was expressed in
S. albus using an integrative vector under the control of
the ermE*p promoter (pCPPimM). Upon integration of
the vector into the S. albus chromosome, we detected
the appearance of small peaks with the characteristic
absorption spectra of heptaenes (Fig. 3A). These peaks,
although small, were reproducible and clearly showed a
significant increase in the production yields (fourfold)
(Fig. 3B). Mass analysis showed ions of m/z 1111, 1109,
1109 and 1093 [M + H]+ and co-migration with pure
candicidins I, II, III and IV respectively, used as standard
(Fig. 4). Interestingly, we also observed several peaks in
the chromatogram with a later chromatographic retention
and another peak with an earlier retention time (Fig. 3A).
Mass analyses of these peaks showed ions of m/z 255,
549, 535 and 521 [M + H]+ respectively, and absorption
spectra with maxima at 229 and 319 nm. Co-migration
with pure samples used as standards revealed that they
corresponded to different members of the antimycins
family (antimycins A1, A2 and A3) and its biosynthetic
precursor antimycic acid (Fig. 4). Antimycins showed a
magnified production yield upon expression of PimM
(29-fold) (Fig. 3B). A careful reanalysis of the S. albus
genome prompted us to identify one of the PKS-NRPS
clusters located in the vicinity of the candicidin cluster
(genes sshg_00054 to sshg_00069) as the putative
antimycin cluster (Fig. 4). This cluster showed simi-
larity with other antimycin clusters described from
Streptomyces S4, Streptomyces ambofaciens and other
Streptomyces strains (Seipke et al., 2011; Yan et al.,
2012; Aigle et al., 2013). In the S. albus candicidin cluster,
there is a pimM homologous gene (sshg_00078). We also
expressed this gene (pIB00078) in S. albus using the
same integrative vector and we obtained similar results as
with PimM (data not shown).
Identification of the paulomycin gene cluster
Analysis of the genome sequence of S. albus J1074 for
the presence of gene clusters coding for glycosylated
secondary metabolites only revealed the presence of one
cluster containing genes involved in the biosynthesis of
6-deoxyhexoses (cluster 23). This cluster would comprise
a region of approximately 60 kb and, in addition to several
genes involved in 6-deoxysugar biosynthesis, two
glycosyltransferases and three putative acyltransferases,
we also observed the presence of genes coding for
enzymes acting on chorismate to generate 3-
hydroxyanthranilic acid or other chorismate-derived com-
pounds. We therefore anticipated that the compound
coded by this cluster could contain a central core derived
from chorismate, which would be glycosylated with two
deoxysugars and it should contain three acylations. To
identify the compound produced by this cluster, we gen-
erated a mutant (S. albus B29) by the simultaneous
deletion of two consecutive genes involved in chorismate
modification, sshg_05327 and sshg_05328 that would
code for an anthranilate synthase and an isochorismatase
respectively. Inactivation of these genes produced the
disappearance of five peaks from the chromatogram
(Fig. 5A). Two of them (peaks 6 and 7) shared a similar
absorption spectrum with maxima at 244 and 321 nm and
mass analysis revealed ions of m/z 648 and 662 [M + H]+
respectively. The other three peaks (peaks 8, 9 and 10)
shared a different spectrum with maxima at 234, 275 and
323 nm and masses of m/z 701, 773 and 787 [M + H]+
respectively. At this stage, it is important to mention that
the presence of these five peaks in ethyl acetate extracts
of S. albus J1074 was very variable and we could not find
a reproducible pattern for production of these compounds
using different batches of media or changing the culture
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media. The five compounds were purified and found to
correspond to paulomycin A (peak 10), paulomycin B
(peak 9), paulomycin E (peak 8), paulomenol A (peak 7)
and paulomenol B (peak 6) by comparing their chromato-
graphic mobilities, absorption spectra, masses and
co-migration with authentic samples of these compounds
(Braña et al., 2014). These compounds were originally
isolated from S. paulus (Argoudelis et al., 1982; 1988a,b).
The main difference between the two groups of com-
pounds is the presence in the paulomycins of an acylation
with a paulic acid residue containing an isothiocyanate
residue that is not present in paulomenols and that is
responsible of the absorbance peak at 275 nm observed
in paulomycins (Argoudelis et al., 1988b). Paulomenols
have been proposed to be true intermediates in the
biosynthesis of paulomycins (Argoudelis et al., 1988b).
However, some experiments prompted us to speculate
that perhaps paulomenols were not real intermediates but
rather degradation products of paulomycins. To answer
this question, we carried out feeding experiments using as
biotransformation host the non-producing deletion mutant
described before (S. albus B29) blocked in early steps
of the biosynthesis of paulomycins (Fig. 6). We fed
paulomenol A to this mutant after 48 h of growth, and after
a further 48 h, we could not observe any conversion of
paulomenols into paulomycins (Fig. 6A). In contrast,
when we fed the same mutant with paulomycin A, there
was a progressive appearance of paulomenol A in parallel
Fig. 3. A. UPLC chromatograms, monitored at 244 nm, of S. albus::pCPPimM expressing regulatory gene pimM cloned in pIB139 and
S. albus::pIB139 used as a control, both grown during 7 days in R5A liquid medium. The arrows indicate the mobility of candicidins and
antimycins used as standards. B. Production of candicidins and antimycins by S. albus J1074 [wild-type (WT)], S. albus::pIB139 (pIB139)
and S. albus::pCPPimM (pCPPimM) grown during 7 days in R5A liquid medium.
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to a decrease in paulomycin A (Fig. 6B). These experi-
ments demonstrated that paulomycin A was quite unsta-
ble and paulomenols arise as degradation products upon
incubation. Therefore, the conclusion is that paulomenols
are not real biosynthetic intermediates in the biosynthesis
of paulomycins but rather degradation products.
Discussion
Filamentous bacteria of the actinomycetes family are
amazingly prolific in the number of bioactive they can
produce. About 75% of the antibiotics are produced by
actinomycetes and most of them are synthesized by the
genus Streptomyces (Demain, 2013). Nevertheless, in
the last decade, the number of novel chemical entities
from actinomycetes has declined concomitantly with a
decrease of new drug discovery by the pharmaceutical
industry. However, the development of whole genome-
sequencing technology and its application to actinomy-
cetes has revealed that these microorganisms have a
greater potential for the production of bioactive natural
products that was anticipated (Challis, 2008; Corre and
Challis, 2009; Nett et al., 2009). Many Streptomyces
species, previously known to produce one or two
bioactive compounds, have been shown to possess gene
clusters for a larger number of secondary metabolites.
However, most of them are not expressed during standard
fermentations (Olano et al., 2008; Baltz, 2011). Therefore,
there is a big potential in actinomycetes for the discovery
of novel bioactive natural products that can be useful for
clinical or pharmaceutical applications. A key issue for the
success in finding novel compounds is to find strategies to
turn on (or turn up) the expression of these cryptic or low
(or non) expressed biosynthesis pathways to identify the
corresponding compounds and to test their biological
activities. We have applied three different strategies
for the activation and identification of silent/cryptic
biosynthesis pathways in S. albus J1074: insertion of a
strong promoter, overexpression of a positive regulatory
gene and generation of a non-producing mutant.
Streptomyces albus J1704 is a Streptomyces strain not
known for its capability to produce a number of bioactive
compounds but widely used by researchers in the
actinomycetes field as a host for gene expression.
Bioinformatic analysis of the genome of S. albus J1074
showed that in agreement with what has been found in
Fig. 4. Genetic organization of S. albus J1074 clusters 4 and 5 involved in the biosynthesis of antimycins and candicidins, respectively, and
chemical structure of compounds of these families.
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other actinomycetes, it possesses a large number of gene
clusters for secondary metabolites. Assuming that the
lack of expression of some gene clusters could be due to
the absence of some signals to be recognized by specific
promoter regions of the cluster, we selected as one of the
strategies the insertion of a strong and constitutive pro-
moter in front of some key genes of selected clusters. This
was the promoter of the erythromycin resistance genes,
ermE*p. The proof of concept indicating that this strategy
could function was successfully obtained through the
activation of the expression of a small cluster coding for
the blue pigment indigoidine. This strategy was also used
to activate the expression of a cluster coding for a hybrid
PK-NRP compound of the polycyclic tetramate macro-
lactams family. Insertion of the ermE*p in front of two
genes of the cluster induced the biosynthesis of two novel
compounds of this family, 6-epi-alteramides A and B,
epimers at position 6 of alteramides A and B, compounds
isolated from the bacterium Alteromonas sp. living in sym-
biosis with a marine sponge (Shigemori et al., 1992). This
approach bypasses the natural induction of the expres-
sion of the cluster by the corresponding intracellular
signal.
A second strategy we have used for cluster activation
was the overexpression of positive regulatory genes. This
is not a novel strategy for yield enhancement and has
been used in a considerable number of systems (Bibb,
2005; Olano et al., 2008). Such approach can use regu-
latory genes from the same cluster or heterologously
expressed regulatory genes from other clusters. We have
used both approaches in two different clusters. The 6-
epi-alteramides gene cluster was also activated by
the overexpression in S. albus of a regulatory gene
(sshg_05706) of the same organism belonging to the
LuxR-family and located 7.6 kb upstream of the hybrid
PKS-NRPS gene. Gene clusters for the biosynthesis of
Fig. 5. A. UPLC chromatograms, monitored at 244 nm, of S. albus J1074 and mutant S. albus B29 in which sshg_05727 and sshg_05728
have been deleted. Peaks absent in the mutant strain are labelled as compounds 6 to 10. B. Chemical structures of paulomenols B (6) and
A (7) and paulomycins E (8), B (9) and A (10).
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different members of this macrolactam family have been
shown to be present in different actinomycetes (Blodgett
et al., 2010). However, when we searched for the pres-
ence of homologous genes to sshg_05706 in several of
these organisms, we could not find any homologous gene
neither in the same position nor in the vicinity of these
clusters. At present, it is not clear if this LuxR-like gene of
S. albus is a pathway-specific regulator or a pleiotropic
regulatory gene positively affecting the expression of
6-epi-alteramides among other functions. However, the
high similarity among these clusters both at the gene
organization level and at the DNA and protein sequence
level and the absence of LuxR-like genes in these
organisms are more in favour to support the view that
the LuxR-like SSHG_05706 of S. albus is a pleiotropic
regulator. Expression of a LuxR-like gene from
S. ambofaciens has been also used to trigger the expres-
sion of stambomycins A-D, 51-membered glycosylated
macrolides (Laureti et al., 2011).
Activation of clusters by the heterologous expression of
a regulatory gene gave us surprising results. From the
bioinformatic analysis, we suspected the presence of a
cluster coding for the polyene candicidins. PimM is a
regulatory gene of the pimaricin pathway in S. natalensis
that combines an N-terminal PAS sensory domain with a
C-terminal helix–turn–helix motif of the LuxR type for DNA
binding (Santos-Aberturas et al., 2010). Insertion of this
gene in the chromosome of S. albus allowed the identifi-
cation of candicidins as products of the corresponding
gene cluster. Surprisingly, a cluster for the biosynthesis of
antimycins was also activated, this cluster being located
in the vicinity of the candicidins cluster. The simultaneous
activation of both clusters suggests that either the two of
them use a common regulatory gene or that there could
be some kind of cross-talk between them. Cross-
regulation between different biosynthesis gene clusters
has been reported in several Streptomyces (Fuente et al.,
2002; Huang et al., 2005). It is interesting to mention that
gene clusters for the biosynthesis of candicidins are quite
frequent in the genomes of actinomycetes (Haeder et al.,
2009; Jørgensen et al., 2009) and quite frequently an
antimycins cluster is also present closely linked to the
candicidins cluster (Seipke et al., 2011; Yan et al., 2012;
this manuscript). Both compounds show antifungal activ-
ity, and it is possible that through evolution actinomycetes
have preserved these biosynthesis pathways to combat
or to protect themselves or associated organisms in which
they live in symbiosis (i.e. ants) of fungal infections.
Glycosylated compounds are quite frequent within
bioactive natural products (Weymouth-Wilson, 1997;
Méndez and Salas, 2001; Salas and Méndez, 2007).
However, searching in the genomes of actinomycetes
reveals that the presence of gene clusters for
glycosylated compounds is rare in this group of organ-
isms. In the genome of S. albus only one cluster for a
glycosylated compound is present, and it was not identi-
fied with ANTISMASH. We identified the compounds pro-
duced by this cluster using a third strategy, the generation
of a non-producing mutant by deleting two key genes in
the cluster. We cannot consider this cluster as silent/
cryptic because the peaks corresponding to paulomycins
and paulomenols were present in ethyl acetate extracts of
Fig. 6. A. UPLC chromatograms, monitored at 244 nm, of mutant S. albus B29 grown in R5A liquid medium and fed with 50 μg ml−1 of
paulomenol A. B. UPLC chromatograms, monitored at 244 nm, of mutant S. albus B29 grown in R5A liquid medium and fed with 50 μg ml−1 of
paulomycin A.
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the wild-type strain. However, regulation of the expression
of this cluster seems to be very loose because there were
clear qualitative and quantitative variations in the pres-
ence and levels of production of the five compounds.
It is worth mentioning that two of these compounds,
paulomenols A and B, were initially supposed to be inter-
mediates in the biosynthesis of paulomycins (Argoudelis
et al., 1988b). However, they were not converted into
paulomycins when fed to a mutant blocked in early stages
of the biosynthesis while feeding paulomycins gave rise to
the appearance of paulomenols. This is a clear indication
of the instability of paulomycins that could easily lose the
paulic acid residue, thus generating paulomenols. Accord-
ing to this experimental evidence, paulomenols would not
be real biosynthetic intermediates but rather degradation
products.
In conclusion, we have demonstrated the presence in
S. albus J1074 of gene clusters for the biosynthesis of
two hybrid PK-NRP (antimycin and 6-epi-alteramides), a
type I PK (candicidin), an NRP (indigoidine) and a
glycosylated family of compounds (paulomycins). Activa-
tion of the expression of these clusters was achieved by
insertion of a strong and constitutive promoter and
through the overexpression of positive regulatory genes.
In the case of paulomycins, the identification came from
comparison of the HPLC profiles between the wild-type
strain and a non-producing mutant. Several other clus-
ters are also present in S. albus, and we are now pro-
ceeding using these and other strategies to attempt the
identification of all bioactive compounds produced by this
organism.
Experimental procedures
Strains, culture conditions and plasmids
Bacterial strains used in this work were S. albus J1074
(Chater and Wilde, 1976), Escherichia coli DH10B
(Invitrogen, Grand Island, NY, USA) and ET12567 (pUB307)
(Kieser et al., 2000) used for subcloning and intergeneric
conjugation respectively. Growth medium for S. albus and
mutants was tryptone soya broth; A medium was used for
sporulation (Fernández et al., 1998) and R5A as production
medium (Fernández et al., 1998). Escherichia coli media
were those described in the literature (Sambrook et al.,
1989). When plasmid-containing clones were grown, the
medium was supplemented with the appropriate antibiotics:
100 μg ml−1 ampicillin, 20 μg ml−1 tobramycin, 25 μg ml−1
apramycin, 50 μg ml−1 thiostrepton, 10 μg ml−1 tetracycline,
25 μg ml−1 chloramphenicol or 50 μg ml−1 nalidixic acid.
Plasmids used in this work were pOJ260P (Olano et al.,
2004) and pEFBAoriT, (Horna et al., 2011) for gene disruption
and gene replacement respectively. pEM4T (Menéndez
et al., 2006) and pIB139 (Wilkinson et al., 2002) were used
for gene expression. pLHyg (Olano et al., 2004) was the
source of the hygromycin resistance gene hyg. pCR-BLUNT
(Invitrogen) was used for cloning polymerase chain reaction
(PCR) products. pCPPimM (Antón et al., 2007) was used to
expresses pimM under the control of ermE*p.
DNA analysis of S. albus J1074 chromosome
Computer-aided database searching and sequence analysis
were carried out using the bioinformatic tool ANTISMASH
(Medema et al., 2011; Blin et al., 2013) and the BLAST
program (Altschul et al., 1997). Analysis of PKS- and NRPS-
predicted proteins were carried out using programs ASMPKS
(Tae et al., 2007) and NRPS predictor (Rausch et al., 2005).
DNA manipulation
Deoxyribonucleic acid manipulations were performed accord-
ing to standard procedures for E. coli (Sambrook et al., 1989)
and Streptomyces (Kieser et al., 2000). PCR conditions used
for all amplifications were 97°C, 5 min.; 30 cycles of 95°C,
30 s, 50°C, 45 s and 68°C, 1 min and a final extension cycle
at 68°C, 10 min. Pfx DNA polymerase (Invitrogen) and 2.5%
dimethyl sulfoxide (DMSO) were used for all amplifications.
To introduce the ermE*p promoter in front of the sshg_00313
gene through homologous recombination, a 2 kb fragment
upstream of sshg_00313 containing its start codon was
amplified using oligoprimers SA313A and SA313B (Support-
ing Information Table S1 in Supplementary Information). The
corresponding PCR product was cloned in pCR-BLUNT
(Invitrogen) and confirmed by DNA sequencing. Afterwards
the fragment was subcloned into the BamHI-EcoRI-digested
pOJ260P, where sshg_00313 is located downstream of
ermE*p promoter leading to plasmid pOJ313.
pOJ5712 and pOJ5713 were generated to clone the
ermE*p promoter in front of the sshg_05712 and sshg_05713
genes through homologous recombination. A 1.53 kb PCR
fragment containing the start codon of sshg_05712 was
amplified using oligoprimers SA5712A and SA5712B (Sup-
porting Information Table S1). The PCR product was cloned
in pCR-BLUNT and then subcloned into the PstI-XbaI-
digested pOJ260P, leading to pOJ5712. pOJ5713 was gen-
erated using the same approach by amplification of a 1.58 kb
PCR fragment, containing the start codon of sshg_05712,
using oligoprimers SA5713A and SA5713B (Supporting Infor-
mation Table S1).
For the expression of ssh_05706 and sshg_00078 (under
the control of ermE*p) in S. albus J1074, the corresponding
genes were amplified by PCR. The sshg_05706 gene was
amplified as a 2628 bp fragment using oligoprimers 11R1A1
and 11R1B1 (Supporting Information Table S1). Oligoprimers
078FW and 078RV (Supporting Information Table S1) were
used to amplify an 800 bp fragment containing sshg-00078.
After verification by sequencing of each PCR fragment, these
were subcloned into the BamHI-EcoRI digested pEM4T (for
ssh_05706) or pIB139 (for sshg_00078) leading to constructs
pEM4T5796 and pIB00078 respectively.
Deletion of genes sshg_05327 and sshg_05328 was
accomplished by amplification of two DNA fragments of
1.5 kb. Fragment A, amplified using the oligoprimers
SA5238FW and SA5328RV (Supporting Information
Table S1), was cloned into SpeI-SphI-digested pEFBAoriT
leading to pT5328A. Fragment B, amplified using the
oligoprimers SA5327FW and SA5327RV (Supporting Infor-
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mation Table S1), was cloned into NdeI-BamHI-digested
pT5328A, leading to pT5328/27 where fragments A and B are
flanking the apramycin resistance gene aac(3)IV. Finally,
pT5328/27 was digested with XbaI, and the gene hyg from
pLHyg was subcloned as a SpeI-NheI fragment to obtain
plasmid p5328/27Hyg used for the generation of S. albus
mutant B29.
Analysis of metabolites by ultra performance liquid
chromatography (UPLC) and liquid
chromatography–mass spectrometry (LC-MS)
Whole cultures were extracted with ethyl acetate containing
1% formic acid (to enhance the extraction of compounds
containing ionizing groups) and analysed by reversed phase
chromatography in an Acquity UPLC instrument fitted with a
BEH C18 column (1.7 μm, 2.1 × 100 mm; Waters), with
acetonitrile and 0.1% trifluoroacetic acid (TFA) as solvents.
Samples were eluted with 10% acetonitrile for 1 min, followed
by a linear gradient from 10% to 100% acetonitrile over 7 min,
at a flow rate of 0.5 ml min−1 and a column temperature of
35°C. For HPLC-MS analysis, an Alliance chromatographic
system coupled to a ZQ4000 mass spectrometer and a
SunFire C18 column (3.5 μm, 2.1 × 150 mm; Waters) was
used. Solvents were the same as above and elution was
performed with an initial isocratic hold with 10% acetonitrile
during 4 min followed by a linear gradient from 10% to 88%
acetonitrile over 26 min, at 0.25 ml min−1. MS analysis were
done by electrospray ionization in the positive mode, with a
capillary voltage of 3 kV and a cone voltage of 20 V. Detec-
tion and spectral characterization of peaks was performed in
both cases by photodiode array detection in the range from
200 nm to 500 nm, using EMPOWER software (Waters) to
extract bidimensional chromatograms at different wave-
lengths, depending on the spectral characteristics of the
desired compound.
Isolation of 6-epi-alteramides
Strains S. albus::pOJ5712 and S. albus::pOJ5713 were
grown in R5A medium without sucrose for the purification of
6-epi-alteramide A (1) and B (2) respectively. In each case, 40
Erlenmeyer flasks (250 ml), each containing 50 ml of
medium, were inoculated with spores and incubated in an
orbital shaker (Climo-Shaker ISF4-X, Adolf Kühner AG,
Basel, Switzerland) at 30°C and 250 r.p.m. during 3 days.
The cultures were centrifuged, the supernatants were dis-
carded and the pellets were extracted twice with ethyl acetate
acidified with 1% formic acid. The organic extracts were
evaporated in vacuo, and the resulting dry extract was
re-dissolved in 3 ml of a mixture of DMSO and methanol
(1:1). The compounds of interest were purified by preparative
HPLC using a SunFire C18 column (10 μm, 10 × 250 mm;
Waters). Compounds were chromatographed with mixtures
of acetonitrile and 0.05% TFA in water in isocratic conditions
optimized for each peak at 7 ml min−1. After every purification
step, the collected compounds were diluted fourfold with
water and were desalted and concentrated by solid-phase
extraction (Sep-Pak C18, Waters). Finally, the compounds
were dissolved in tert-butanol and lyophilized. The resulting
yields were 2.7 mg of 6-epi-alteramide A (1) and 13.8 mg of
6-epi-alteramide B (2).
Structural characterization of 6-epi-alteramides
6-epi-alteramide A (1) and B (2) were purified from cultures of
S. albus::pOJ5712 and of S. albus::pOJ5713 respectively.
Their structural elucidation was carried out using 1D 1H, 1D
13C, 2D 1H COSY, 2D 1H TOCSY, 1H, 13C heteronuclear
multiple-quantum correlation-edited and heteronuclear
multiple-bond correlation NMR experiments using deuterated
methanol (CD3OD) as solvent (Supporting Information
Figs. S1–S15 in Supplementary Information). NMR spectra
were recorded at 24°C on a Bruker AVANCE III-600 MHz
using a 1.7 mm microcryoprobe (Bruker). 6-epi-alteramide A
and B NMR data are shown in Tables S2–S4.
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